SpectrumX announces lab data showing its Spectricept™ product neutralises C. difficile spores within minutes
Lab tests shows that Spectricept™ neutralises a variety of common pathogens, including the spores of C. difficile, which are commonly found in hospitals and health care facilities and are a cause of hospital-acquired infection. Patent-pending formula benefiting from the sporicidal qualities of hypochlorous acid (HOCl) is pH neutral and skin-safe, with a ‘kill time’ of […]
